These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

954 related articles for article (PubMed ID: 15192785)

  • 1. The epidemiology of cholangiocarcinoma.
    Shaib Y; El-Serag HB
    Semin Liver Dis; 2004 May; 24(2):115-25. PubMed ID: 15192785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for cholangiocarcinoma.
    Ben-Menachem T
    Eur J Gastroenterol Hepatol; 2007 Aug; 19(8):615-7. PubMed ID: 17625428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a hospital-based case-control study.
    Shaib YH; El-Serag HB; Nooka AK; Thomas M; Brown TD; Patt YZ; Hassan MM
    Am J Gastroenterol; 2007 May; 102(5):1016-21. PubMed ID: 17324130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence rates of intra- and extrahepatic cholangiocarcinomas in Denmark from 1978 through 2002.
    Jepsen P; Vilstrup H; Tarone RE; Friis S; Sørensen HT
    J Natl Cancer Inst; 2007 Jun; 99(11):895-7. PubMed ID: 17551150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a case-control study in China.
    Tao LY; He XD; Qu Q; Cai L; Liu W; Zhou L; Zhang SM
    Liver Int; 2010 Feb; 30(2):215-21. PubMed ID: 19840244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholangiocarcinoma: descriptive epidemiology and risk factors.
    de Martel C; Plummer M; Franceschi S
    Gastroenterol Clin Biol; 2010 Mar; 34(3):173-80. PubMed ID: 20202771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hepatocellular carcinoma and cholangiocarcinoma--different prognosis, pathogenesis and therapy].
    Tischoff I; Tannapfel A
    Zentralbl Chir; 2007 Aug; 132(4):300-5. PubMed ID: 17724632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholangiocarcinoma: epidemiology, mechanisms of carcinogenesis and prevention.
    Parkin DM; Ohshima H; Srivatanakul P; Vatanasapt V
    Cancer Epidemiol Biomarkers Prev; 1993; 2(6):537-44. PubMed ID: 8268770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis B virus infection and intrahepatic cholangiocarcinoma in Korea: a case-control study.
    Lee TY; Lee SS; Jung SW; Jeon SH; Yun SC; Oh HC; Kwon S; Lee SK; Seo DW; Kim MH; Suh DJ
    Am J Gastroenterol; 2008 Jul; 103(7):1716-20. PubMed ID: 18557716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study.
    Welzel TM; Graubard BI; El-Serag HB; Shaib YH; Hsing AW; Davila JA; McGlynn KA
    Clin Gastroenterol Hepatol; 2007 Oct; 5(10):1221-8. PubMed ID: 17689296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Case-control study of risk factors in cholangiocarcinoma].
    Tao LY; He XD; Cai L; Liu W; Ji WJ; Zhao L; Zhang SM
    Zhonghua Zhong Liu Za Zhi; 2009 Oct; 31(10):759-63. PubMed ID: 20021829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiological survey of biomarkers of hepatitis virus in patients with extrahepatic cholangiocarcinomas.
    Qu Z; Cui N; Qin M; Wu X
    Asia Pac J Clin Oncol; 2012 Mar; 8(1):83-7. PubMed ID: 22369448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrahepatic cholangiocarcinoma: new insights in pathology.
    Sempoux C; Jibara G; Ward SC; Fan C; Qin L; Roayaie S; Fiel MI; Schwartz M; Thung SN
    Semin Liver Dis; 2011 Feb; 31(1):49-60. PubMed ID: 21344350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cholangiocarcinoma--bile ducts cancer].
    Dubaniewicz A; Dubaniewicz A
    Wiad Lek; 2003; 56(1-2):57-60. PubMed ID: 12901270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increasing incidence of cholangiocarcinoma in Crete 1992-2000.
    Mouzas IA; Dimoulios P; Vlachonikolis IG; Skordilis P; Zoras O; Kouroumalis E
    Anticancer Res; 2002; 22(6B):3637-41. PubMed ID: 12552969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Global trends in mortality from intrahepatic and extrahepatic cholangiocarcinoma.
    Bertuccio P; Malvezzi M; Carioli G; Hashim D; Boffetta P; El-Serag HB; La Vecchia C; Negri E
    J Hepatol; 2019 Jul; 71(1):104-114. PubMed ID: 30910538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Risk factors of intrahepatic cholangiocarcinoma: a case-control study].
    Zhou HB; Xu QR; Wang H; Zhou DX; Wang H; Wang Q; Zhou SS; Tu QQ; Sun ZQ; Ai L; Wu MC; Hu HP
    Zhonghua Gan Zang Bing Za Zhi; 2009 Dec; 17(12):935-9. PubMed ID: 20038337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Epidemiology of primary and secondary liver cancers].
    Jepsen P; Kissmeyer-Nielsen P
    Ugeskr Laeger; 2008 Apr; 170(16):1323-5. PubMed ID: 18433588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetes mellitus and increased risk of cholangiocarcinoma: a meta-analysis.
    Jing W; Jin G; Zhou X; Zhou Y; Zhang Y; Shao C; Liu R; Hu X
    Eur J Cancer Prev; 2012 Jan; 21(1):24-31. PubMed ID: 21857525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatobiliary and extra-hepatic malignancies in primary sclerosing cholangitis.
    Bergquist A; Broomé U
    Best Pract Res Clin Gastroenterol; 2001 Aug; 15(4):643-56. PubMed ID: 11492973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 48.